Inter&Co doubles down on SMEs through acquisition of Granito
May 28, 2024 07:33 ET | Inter&Co, Inc
BELO HORIZONTE, Brazil, May 28, 2024 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), announces that Banco Inter S.A. entered into a share purchase agreement to acquire the...
MFIN Logo New (1).jpg
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director Nominees on the BLUE Proxy Card
May 28, 2024 07:30 ET | Medallion Financial Corp.
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN) (“Medallion” or the “Company”) today announced that leading independent proxy advisory firm Institutional...
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
May 28, 2024 07:30 ET | Opthea Limited
Phase 3 program enrolled 1,984 patients across COAST and ShORe trials Trials designed to replicate superiority in visual outcomes demonstrated in Phase 2b Topline data from both pivotal trials...
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
May 28, 2024 07:30 ET | Agrify
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
May 28, 2024 07:30 ET | Apogee Therapeutics, LLC
SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
TGTX 2021 Logo
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
May 28, 2024 07:30 ET | TG Therapeutics, Inc.
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations highlighting study designs for post-marketing studies being...
Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
May 28, 2024 07:30 ET | Venus Concept Inc.
TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that, on May 24, 2024,...
THUMB_1740-12_Silhouette Vertical Full Color.png
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
May 28, 2024 07:30 ET | Abeona Therapeutics Inc.
CLEVELAND, May 28, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its senior management team will participate in a fireside chat at the Jefferies...
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
May 28, 2024 07:30 ET | Clene Inc.
First patient, first visit is planned for early June 2024Enrollment has been expanded by 80% to a maximum of 180 participants‘Real-world’ drug efficacy data will be collected by monitoring potential...
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
May 28, 2024 07:30 ET | Dyne Therapeutics, Inc.
WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for...